Low levels of amyloid-beta and tau proteins, biomarkers of Alzheimer’s disease, in eye fluid were significantly associated with low cognitive scores, according to a new study. These findings indicate that proteins in the eye may be a potential source for an accessible, cost-effective test to predict future Alzheimer’s disease.